Global Reach, Local Expertise

Madrid, Spain

Home   |   Locations   |   Europe   |   Spain   |   Pediatrics   |   START Pediatrics

Community Partner

START Pediatrics is a specialized pediatric oncology clinical research unit located at HM Montepríncipe Hospital in Madrid—marking the first of its kind within Spain’s private hospital sector. Led by Dr. Marta Osuna Marco, a highly experienced pediatric oncologist and hematologist, the unit offers early- and late-phase clinical trial options for children and adolescents, ages 0-18 affected by cancer.

Designed with the child and family at its core, the facility offers a dedicated research area supported by a full team of specialists, including psychologists, physiotherapists, social workers, and educators. Additionally, there is one Onco-ICU room within the unit, equipped with remote patient monitoring and positive pressure, enables close oversight of adverse reactions in immunotherapy. Housed within a hospital equipped with over 220 beds, ICU, emergency care, advanced imaging, and pediatric surgical expertise, START Pediatrics combines world-class infrastructure with a mission to advance pediatric cancer research—reinvesting trial proceeds to help drive future breakthroughs.

To learn more, please visit: https://oncopediatrialopezibor.es/es-es/.

Explore START Pediatric's Clinical Trials

Clinical Trials

Explore START Pediatric's Clinical Trials

If you are interested in participating in a clinical trial at START, we encourage you to reach out to us. Our team will guide you through the process, answer any questions you may have, and help determine if you are eligible for any ongoing trials.

Principal Investigators

The Phase I Clinic

  • 2 Exam Rooms
  • 1 Treatment Chair
  • 1 Treatment Chair for blood draw and procedures, as needed
  • START Pediatrics has an on-site laboratory that can perform same day testing. This includes:
      • Complete Blood Count (CBC)
      • Renal function
      • Liver function
      • Hepatitis/HIV tests
      • Coagulation tests
      • Tumor markers
  • Crash cart complete with intubation equipment
  • Infusion pumps
  • Syringe pumps
  • Electronic vital signs monitoring
  • All equipment is annually inspected and calibrated
  • Our clinicians have experience with utilizing ELI 150 and ELI 250 equipment from central vendors.

Investigational Drug Section (IDS)

Drug Shipment Address

Attention: TBD
START Pediatrics
HM Montepríncipe – Unidad de Hematología y Oncología Pediátrica
Avda. de Montepríncipe, 25, Floor -1
28660, Madrid

Pharmacy Equipment

  • All equipment is annually inspected and calibrated and includes the following:
    • Biological safety cabinet
    • Negative pressure clean room
    • Positive pressure anteroom
    • Secure medication storage room with continuous temperature monitoring for both cold storage and room temperature storage
    • 1 pharmaceutical grade -20°C freezer
    • 1 pharmaceutical grade -80°C freezer
    • 1 pharmaceutical grade refrigerator 2 – 8°C
    • Room temperature storage shelving (20 – 25°C)

Medication Preparation

  • Detailed storage, handling and preparation instructions are required.
    • Procedure to prepare investigational drug 
    • Compatible IV bags 
    • Compatible IV tubing for infusion pumps

Medication Screening

  • Pharmacists screen and document prestudy concomitant medications using protocol eligibility criteria, Lexicomp and Crediblemeds.org to identify prohibited medications and other potential drug interactions of concern.

Drug Diaries

  • Due to the potential for staff exposure to hazardous materials the IDS will not maintain any empty or partially empty container left from the preparation of investigational doses, this includes both IV and PO dosage forms.

Pharmacokinetics

PK Shipment Address

Attention: Belén Lapuente Suanzes
START Pediatrics
HM Montepríncipe – Unidad de Hematología y  Oncología Pediátrica
Avda. de Montepríncipe, 25, Floor -1
28660, Madrid

Laboratory Equipment

All equipment is annually inspected and calibrated and includes the following:

  • Refrigerated / room temperature centrifuges (3000g(rcf )/4400 rpm)
  • -80°C / -20°C freezer with continuous temperature monitoring
  • Pharmaceutical grade refrigerator 2 – 8°C
  • Room temperature storage shelving

Shipping Capabilities

PK department staff are IATA shipping certified. Specimens may be shipped same day, weekly, or monthly.

Biopsy Specimens

PK department staff are present at the time of biopsy and process specimens according to protocol requirements.

Archival Specimens

  • PK department staff request and process archival specimens 
  • Tumor blocks or unstained or slides are obtained and sent to sponsor or designee

Specialty Labs

PK department staff routinely process and ship to Central Lab specimens such as biomarkers, PBMCs, DNA, hair follicle specimens, and other specialty labs.

Regulatory Affairs & Data Management

Data Entry Capabilities

  • Every study has a dedicated START Clinical Research Assistant (CRA). 
  • START has experience with a wide variety of electronic data capture systems (i.e., Medidata RAVE, InForm, Tempo, DataTrak, etc.). 
  • START ensures clean, accurate, and timely data entry and query resolution. 
    • 10 business days for data entry 
    • 5 business days for query resolution

On-site Monitoring Area

  • 1 monitoring workstations with high-speed Internet and desktop computers for accessing the EMR
  • Wi-Fi is available for EDC access
  • Basic office supplies, copier, and telephone are available
  • On-site monitoring hours are Monday – Friday, 8am – 3pm, with flexibility, provided that any adjustments are agreed upon between the coordinators and the monitors

Remote Monitoring Services

  • START’s remote monitoring service allows the monitor to have access to our EMR and e-ISF (Veeva) systems without having to be on-site. 
  • Remote monitoring hours are Monday – Friday, 8am – 3pm, with flexibility, provided that any adjustments are agreed upon between the coordinators and the monitors.

Scheduling Monitoring Visits

  • The assigned START CRA is the main point of contact for the scheduling of all on-site and/or remote monitoring visits (i.e., initial, interim, and close-out visits, etc.). 
  • Monitor visits must be scheduled at least 30 days in advance. 
  • Requests for co-monitors must be reviewed by the study team and approved by the Principal Investigator.

Hybrid Monitoring (Onsite and Remote)

  • Monitors will be required to conduct on-site and remote visits during the following times: 
    • First monitoring visit and once per quarter may be conducted ON-SITE 
    • All other visits will be conducted REMOTELY

Contact

Get in Touch

Let’s save lives—together. Fill out the form to connect with us today, whether you’re ready to jump in or just have questions. Every action counts.

Other Locations